Software to calculate the right dose of medicine for heart failure patients gets breakthrough device designation

Biofourmis, a Boston-based digital health startup, recently received breakthrough designation for its digital therapeutic to help ensure heart failure patients receive medications that are consistent with clinical evidence at the right dose.